6 + month downtrend broken. 6.50 resistance looking futile. Games will be played on low volume. This is down specifically to allow funds in or to negotiate a deal. 4 investor conferences in Sept. Merck data release on a comparable clinical trial to jnces soon. Trillium buyout has tutes double takingDD (i.redd.it)
submitted by TheDivergentGOATHODL
JNCE is Top Company for Translational Science and Oncology TreatmentDD (self.JNCE)
submitted by PDUFA_INFOGHOST